Page last updated: 2024-08-25

imidacloprid and Respiratory Tract Infections

imidacloprid has been researched along with Respiratory Tract Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capelli, G; Di Cesare, A; Diakou, A; Dimzas, D; Morelli, S; Parrinello, C; Pollmeier, M; Schaper, R; Traversa, D1
Braun, G; Di Cesare, A; Günther, L; Morganti, G; Petry, G; Rueca, F; Schaper, R; Traversa, D; Veronesi, F1

Trials

1 trial(s) available for imidacloprid and Respiratory Tract Infections

ArticleYear
Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate
    Parasites & vectors, 2019, Nov-04, Volume: 12, Issue:1

    Topics: Animals; Cat Diseases; Cats; Drug Combinations; Feces; Female; Greece; Larva; Macrolides; Male; Metastrongyloidea; Neonicotinoids; Nitro Compounds; Respiratory Tract Infections; Strongylida Infections

2019

Other Studies

1 other study(ies) available for imidacloprid and Respiratory Tract Infections

ArticleYear
Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate
    Parasitology research, 2017, Volume: 116, Issue:Suppl 1

    Topics: Administration, Topical; Animals; Antinematodal Agents; Capillaria; Dog Diseases; Dogs; Drug Combinations; Enoplida Infections; Female; Imidazoles; Macrolides; Neonicotinoids; Nitro Compounds; Respiratory Tract Infections; Treatment Outcome

2017